VectorY Therapeutics

VectorY Therapeutics is a clinical-stage biotechnology company developing vectorized antibody therapies for neurodegenerative diseases, combining antibody engineering with AAV-based delivery to generate durable, precision-targeted treatments. Its lead program VTx-002 targets pathological TDP-43 in ALS and is being evaluated in the global Phase 1/2 PIONEER-ALS clinical trial, with follow-on programs directed at Huntington's disease, frontotemporal dementia and Alzheimer's disease. The company operates from Amsterdam with a US office in Boston.

  • Biotechnology
  • Clinical Trials
  • Healthtech
  • Pharmaceuticals
  • Targeted Protein Degraders
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 11, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 11, 2026

    EUR 82.6M

    Series A

    Led by Forbion

    • BioGeneration Ventures
    • Forbion
    • Invest-NL
    • EQT Life Sciences
    • Eli Lilly and Company
    • Angelini Ventures
    • Insight Partners
    • MRL Ventures Fund
    • ALS Investment Fund

    Article coming soon.

Pricing

Research VectorY Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if VectorY Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational